Article

Can Continuous Glucose Monitors Improve Outcomes in Type 2 Diabetes?

CGMs can be helpful in managing patients with type 2 diabetes or any diabetes patient in the hospital setting, according to several experts.

BOSTON - April 22, 2010 — CGMs, primarily used for monitoring blood glucose levels in patient with type 1 diabetes mellitus, can be helpful in managing patients with type 2 diabetes or any diabetes patient in the hospital setting according to experts today at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress.

An emerging use for CGM is for type 2 diabetes therapy. Though not a permanent replacement for finger prick tests, putting a patient on CGM for several weeks will provide clinicians with a better picture of what is truly happening with the patient’s blood glucose

levels.

“The physician will then be able to chart out the best possible treatment plan for their patient,” Dr. Robert M. Cuddihy, endocrinologist and medical director at the International

Diabetes Center at Park Nicollet said.

The results may be especially beneficial in hospital settings. Recent studies, such as NICE-SUGAR have raised questions concerning the merits of tight glycemic control in the hospital setting. CGMs allow clinicians to review minute-by-minute trends, thereby minimizing

glycemic excursions and “tipping the scales” in favor of glycemic control.

“Good glycemic control [in the hospital] is still relevant if CGMs are constantly checked,” Dr. Cuddihy said.

Source: The American Association of Clinical Endocrinologists

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
Country-Level Socioeconomic Status, Healthcare Impact AKI Outcomes in Cirrhosis
© 2024 MJH Life Sciences

All rights reserved.